A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing
cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease
or are at risk of a heart attack or stroke. The study drug will be administered
subcutaneo...
Age: 18 years - 66+
Gender: All
Laminar LAAX Pivotal IDE Study
The goal of this clinical trial is to compare the Laminar Left Atrial Appendage Closure
System to commercially available left atrial appendage closure devices. This procedure is for
patients with non-valvular atrial fibrillation who are at increased risk for stroke,...
Age: 18 years - 66+
Gender: All
Strategy for Improving Stroke Treatment Response
SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding
trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal
antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.
Age: 18 years - 66+
Gender: All
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
Age: 18 years - 66+
Gender: All
Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry
Vagal Nerve Stimulation is a novel proven therapy for patients with chronic ischemic stroke.
The primary objective of this registry is to assess the safety of vagal nerve stimulation for
stroke recovery through monitoring the occurrence of serious adverse events ass...
Age: 18 years - 66+
Gender: All
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
Researchers are looking for a better way to prevent an ischemic stroke which occurs when a
blood clot travelled to the brain in people who within the last 72 hours had:
- an acute stroke due to a blood clot that formed outside the heart (acute
non-cardioembolic ...
Age: 18 years - 66+
Gender: All
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospec...
Age: 18 years - 66+
Gender: All
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the
Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by
removing thrombus in patients presenting within 24 hours of onset with an ischemic strok...
Age: 18 - 85 years
Gender: All
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
Stroke occurs when a blood clot causes a blockage in a blood vessel (artery) within the
brain. This type of stroke is called an ischemic stroke and carries a high risk of disability
or death. Stroke must be treated very fast. Any delay of even 10 minutes can result ...
Age: 18 years - 66+
Gender: All
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or
ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of
ischemic stroke, intracerebral hemorrhage, or vascular death.
Age: 30 years - 66+
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Amplatzer Amulet LAAO vs. NOAC
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA
occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for
ischemic stroke and who are recommended for long-term NOAC therapy.
The clinical in...
Age: 18 years - 66+
Gender: All
Endovascular Therapy for Low NIHSS Ischemic Strokes
This study will test the hypothesis that patients presenting within 8 hours of onset with
cerebral ischemia in the setting of proximal large vessel occlusions (LVO) and low baseline
NIHSS scores (0-5) will have better 90-day clinical outcomes (mRS distribution) with...
Age: 18 years - 66+
Gender: All
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System
in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure
within 8 hours of last known well.
Age: 18 years - 66+
Gender: All
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will
improve clinical outcomes and quality of life (QOL) compared to single arterial grfating
(SAG).
The specific aims of ROMA:Women are:
Aim 1: Determine the impact of ...
Age: 18 years - 66+
Gender: Female
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
The purpose of this study is to determine whether a single treatment with administration of
400 Units NT 201 (botulinum toxin) is superior to placebo (no medicine) for the treatment of
lower limb spasticity caused by stroke or traumatic brain injury (Main Period). P...
Age: 18 - 85 years
Gender: All
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite
outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with
recent ICH and atrial fibrillation (AF).
Secondary Aim: To determine if apixaban...
Age: 18 years - 66+
Gender: All
XIENCE 28 USA Study
The XIENCE 28 USA Study is prospective, single arm, multi-center, open label, non-randomized trial to evaluate safety of 1-month (as short as 28 days) dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding (HBR) undergoing percutaneous coronary interventi...
Age: 18 - 100 years
Gender: All
IIT Age-related Macular Degeneration (AMD) and Cardiovascular Disease
Age-related macular degeneration (AMD) is the leading cause of blindness in our country, and heart attack and stroke are leading causes of death. We have discovered that AMD and these lethal systemic diseases may be linked by a special form of AMD called “reticula...
Age: 40 - 75 years
Gender: All